Autres langues Novartis India Limited

Actions

NOVARTIND

INE234A01025

Produits pharmaceutiques

Temps Différé Bombay S.E. Autres places de cotation 10:54:12 14/05/2025			Varia. 5j.	Varia. 1 janv.
856,95 ^INR	+0,72 %		+9,58 %	-6,83 %

09/05	Novartis India Limited publie ses résultats pour le quatrième trimestre et l'exercice clos le 31 mars 2025	CI
01/04	La volatilité des marchés fait échouer le projet de Novartis de vendre sa participation dans sa branche indienne	CI

Autres langues

Novartis India Limited Recommends Final Dividend for the Financial Year Ended March 31, 2025	10/05
Novartis India Dividend Of 25 Rupees Per Share	09/05
Novartis India Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025	09/05
Market Volatility Derails Novartis' Plan to Sell Stake in its India Arm	01/04
Novartis India's Net Profit Declines in Fiscal Q3	28/01
Novartis India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	28/01
Novartis India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	25/10/24
PE Firms Reportedly Queue Up for Novartis' Indian Arm	12/10/24
Alkem Labs Reportedly in Talks to Acquire Novartis India from Its Swiss Parent	26/09/24
Novartis India Clarifies on Reports Indicating Alkem's Interest in It	26/09/24
Novartis India Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	29/07/24
Novartis India Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	10/05/24
Novartis India Limited Recommends Dividend for the Financial Year Ended March 31, 2023, Payable on or After August 5, 2024	10/05/24
Novartis India Limited Announces Appointment of Chandni Maru as Company Secretary and Compliance Officer	08/05/24
Novartis India Limited Announces Resignation of Nikhil Malpani as Company Secretary and Compliance Officer, Effective from April 30, 2024	01/04/24
Novartis Eyes Sale of Listed Unit in India	22/03/24
Global markets live: Apple, Nintendo, Super Micro Computer, Currys, ABB...	19/02/24
Aktien Schweiz Schluss: SMI rückt dank Schwergewichten weiter vor	19/02/24
Swiss Market Index Closes in the Green on Healthcare Stocks Boost	19/02/24
Aktien Schweiz: SMI tritt bei trägem Handel auf der Stelle	19/02/24
Novartis valuta cessione filiale quotata in India	19/02/24
Novartis Launches Strategic Review of Listed Indian Business	19/02/24
Dr. Reddy's Laboratories Denies in Race to Acquire Novartis' Stake in Novartis India	19/02/24
Morning Briefing - Markt Schweiz	19/02/24
Aktien Schweiz Vorbörse: Zaghafter Wochenstart erwartet	19/02/24

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Novartis India Limited

Actions

NOVARTIND

INE234A01025

Produits pharmaceutiques

Autres langues

Filtres